Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives (Q89918697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Robert Coombs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

David W Haas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Yoninah S Cramer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Catherine Godfrey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Susan L Rosenkranz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Francesca Aweeka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Baiba Berzins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Kristine Coughlin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Laura E Moran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

David Gingrich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Carmen D Zorrilla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Paxton Baker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Susan E Cohn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Kimberly K Scarsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

AIDS Clinical Trials Group A5316 Study Team

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

1 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

Pharmacogenetics and Genomics

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

45-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes

9 April 2020

cites work

1 reference

12 December 2020

JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML.

1 reference

12 December 2020

Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation

1 reference

12 December 2020

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

1 reference

12 December 2020

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

1 reference

12 December 2020

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects

1 reference

12 December 2020

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

1 reference

12 December 2020

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz

1 reference

12 December 2020

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

12 December 2020

Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis

1 reference

12 December 2020

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

1 reference

12 December 2020

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

1 reference

12 December 2020

CYP2B6 (c.516G→T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients

1 reference

12 December 2020

CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients

1 reference

12 December 2020

Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study

1 reference

12 December 2020

Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption

1 reference

12 December 2020

The Effect of Efavirenz on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy HIV-Negative Women

1 reference

12 December 2020

Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption

1 reference

12 December 2020

Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM

1 reference

12 December 2020

Human metabolic individuality in biomedical and pharmaceutical research

1 reference

12 December 2020

Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz

1 reference

12 December 2020

Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women

1 reference

12 December 2020

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

1 reference

12 December 2020

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

1 reference

12 December 2020

Genome-wide association study of sex hormones, gonadotropins and sex hormone-binding protein in Chinese men.

1 reference

12 December 2020

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.

1 reference

12 December 2020

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

1 reference

12 December 2020

Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women

1 reference

12 December 2020

Genomics and metabolomics of muscular mass in a community-based sample of UK females

1 reference

12 December 2020

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

1 reference

12 December 2020

Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes

1 reference

12 December 2020

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study

1 reference

12 December 2020

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks

1 reference

12 December 2020

Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV

1 reference

12 December 2020

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients

1 reference

12 December 2020

Drug interactions between hormonal contraceptives and antiretrovirals

1 reference

12 December 2020

The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.

1 reference

12 December 2020

Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy

1 reference

12 December 2020

Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.

1 reference

12 December 2020

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy

1 reference

12 December 2020

Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART

1 reference

12 December 2020

Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study

1 reference

12 December 2020

10.1097/FPC.0000000000000396

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32106141%20AND%20SRC:MED&resulttype=core&format=json